Business
Bain Capital clinches $1.2 billion deal for Japan's Nichiigakkan after fending off higher bid
Bain Capital clinched a $1.2 billion deal on Tuesday to buy Japanese nursinghome operator Nichiigakkan after fending off a higher, lastminute bid from rival Baring Private Equity Asia (BPEA).
Japan's pandemic woes unravel benefits of 'Abenomics'
Japanese Prime Minister Shinzo Abe's rise to power in 2012 ushered in bold policies known as "Abenomics" that helped revive the economy and boost corporate profits, exports and jobs.
Coronavirus Vaccine by China's Sinopharm to Cost Over Rs 10k, Firm Chief Says 'That's Not a Very High Price'
Sinopharm has said its experimental vaccine could be ready for public use by the end of this year. It has entered a late-stage human test in the United Arab Emirates to gather proof of efficacy for final regulatory approvals.
Carnival hit by ransomware attack, guest and employee data accessed
Carnival Corp said on Monday it launched an investigation after the cruise operator detected a ransomware attack that accessed and encrypted a portion of information technology systems of one of its brands.
Liz Weston: Why taking Social Security early costs too much
Starting Social Security early typically means getting a smaller benefit for the rest of your life. The penalty is steep: Someone who applies this year at age 62 would see their monthly benefit check reduced by nearly 30%.
Income Tax Refund: Govt Not Considering Modifications in ITR Form, Say Sources
Any expansion in reporting under the statement of financial transactions (SFT) will mean that such reporting of high-value transactions to the income tax department will be done by financial institutions.
Market Movement to Hinge on Covid-19 Trend, Global Cues This Week: Analysts
With last week's key macro data showing slow economic recovery and high inflation, experts are of the view that volatility may continue in the market going ahead.
Exclusive: U.S.-China trade deal review postponed as China ramps up farm, energy purchases
The United States and China have delayed a review of their Phase 1 trade deal initially slated for Saturday, sources familiar with the plans told Reuters, citing scheduling conflicts and the need to allow time for more Chinese purchases of U.S. exports.
Coronavirus vaccine developer CureVac shares surge in U.S. debut
Shares of German biotechnology firm CureVac BV nearly tripled in their Nasdaq debut on Friday, marking the first stock market debut of a company developing a potential vaccine to combat the novel coronavirus.
Coronavirus vaccine developer CureVac shares surge 175% in Nasdaq debut
Shares of German biotechnology firm CureVac BV nearly tripled in their Nasdaq debut on Friday, marking the first stock market debut of a company developing a potential vaccine to combat the coronavirus.
Vaccine makers including Moderna must hit U.S. timing goals for full payments
The United States is tying payments for COVID19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna Inc to meet ambitious targets.
Wall Street retreats as retail sales growth slows
The S&P 500 slipped further away from record levels on Friday as domestic retail sales growth slowed in July, adding to worries about a wobbly postpandemic economic recovery in the absence of a new U.S. fiscal stimulus bill.
Factbox: Strait of Hormuz - the world's most important oil artery
The U.S. military on Wednesday said Iranian forces briefly boarded a Liberianflagged oil near the Strait of Hormuz, heightening tensions in the world's busiest oil waterway.
India's July Trade Deficit in Goods at $4.83 Billion, Says Trade Ministry
Merchandise imports contracted 28.40% in July to $28.47 billion from a year ago while exports fell 10.21% to $23.64 billion, data released by the Ministry of Commerce and Industry on Wednesday showed.
Investors in Belarus face 'dictator dilemma', Putin may hold the key
Investors face a classic 'dictator dilemma' in Belarus hold on to securities that benefit from the status quo in a brutal regime, or sell them and sever their ties but which way they go may depend largely on Vladimir Putin's Russia.
Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax deals
Britain will buy potential COVID19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc , the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.